Table 3. Characteristics of XDR-TB cases detected in the Fourth National Anti-Tuberculosis Drug Resistance Survey in Viet Nam, 2011.
| Case | Age | Sex | Region of residence | TB previously treated | HIV status | Pattern of drug resistance for FLDs | Pattern for drug resistance of SLDs |
|---|---|---|---|---|---|---|---|
| 1 | 23 | Male | Central | No | Negative | H; R; S | CM; KM; OFL |
| 2 | 53 | Male | Central | Yes | Negative | E; H; R; S | CM; KM; OFL |
| 3 | 63 | Male | South | Yes | Negative | E; H; R; S | CM; KM; OFL |
| 4 | 46 | Male | South | No | Negative | E; H; R; S | CM; KM; OFL |
| 5 | 48 | Male | South | Yes | Negative | E; H; R; S | AM; CM; KM; OFL |
AM, Amikacin; CM, Capreomycin; E, Ethambutol; FLDs, first-line TB drugs; H, Isonoazid; KM, Kanamycin; OFL, Ofloxacin; R, Rifampicin; SLDs, second-line TB drugs; S, Streptomycin; and TB, tuberculosis.